Symbol
CHRS on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, $0.0001 par value
Latest Disclosed Ownership
6.01M shares
Security Ownership
5.2%

Thomas A. Satterfield, Jr. ownership in Coherus BioSciences, Inc. Common Stock, $0.0001 par value (CHRS)

2025-04-16 - Thomas A. Satterfield, Jr. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.01M shares of Coherus BioSciences, Inc. Common Stock, $0.0001 par value (CHRS). This represents 5.2% percent ownership of the company.